[Duodenal peptic ulcer. Medical therapy].
D000535:Aluminum / Q000627:therapeutic use; D000863:Antacids / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use; D002927:Cimetidine / Q000627:therapeutic use; D004341:Drug Evaluation; D004381:Duodenal Ulcer / Q000188:drug therapy*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D009853:Omeprazole; D010276:Parasympatholytics / Q000627:therapeutic use; D011453:Prostaglandins / Q000627:therapeutic use; D013392:Sucralfate
D000863:Antacids; D000897:Anti-Ulcer Agents; D001562:Benzimidazoles; D006635:Histamine H2 Antagonists; D010276:Parasympatholytics; D011453:Prostaglandins; D013392:Sucralfate; D002927:Cimetidine; D000535:Aluminum; D009853:Omeprazole
Ulcera péptica duodenal. Manejo médico.